And the focus of tumor immunotherapy is tumor antigen.
肿瘤免疫治疗的核心是肿瘤抗原问题。
Our study enables us to further investigate the role of B7 1 in tumor immunotherapy.
本文为研究B7 -1在肿瘤免疫中所起的作用奠定了基础。
Some chemokine can be used in anti-tumor immunotherapy by its chemotactic function on tumor cells.
部分趋化因子通过趋化和调节免疫效应细胞的功能来发挥抗肿瘤免疫作用。
DC vaccines are always made by been pulsed with tumor peptide or complex antigen in anti-tumor immunotherapy.
目前在抗肿瘤免疫治疗中，最常用的负载dc的方式有应用抗原肽和全抗原两种。
This paper reviews current advances in the preparation and the clinical application of dendritic cell-based tumor vaccines for tumor immunotherapy.
就肿瘤免疫治疗中树突状细胞瘤苗的基础研究与临床应用进展予以综述。
NK cells, as the effectors in antibody-dependent cell mediated cytotoxicity, play important roles in anti-tumor immune response. They now have become the hot point in the study on tumor immunotherapy.
NK细胞作为抗体依赖细胞毒作用的效应器，在抗肿瘤免疫中发挥着重要作用，成为目前肿瘤免疫治疗的研究热点。
But the decreased immunogenicity and the body's low immune response to tumor restrict the use of the immunotherapy.
但是，肿瘤的低免疫原性和机体对肿瘤的低免疫反应性，使得免疫治疗受到限制。
The research on tumor vaccine has been a key method of tumor active immunotherapy with the development and application of molecular biological and genetic engineering technology.
随着分子生物学及基因工程技术的出现及应用，肿瘤疫苗的研究已成为主动性免疫治疗的重要手段之一。
Immunotherapy involves the manipulation of the immune system - by introducing an antibody or lymphocytes, or immunization with a tumor vaccine - to recognize and eradicate tumor cells.
免疫治疗包括通过导入抗体或淋巴细胞或者通过肿瘤疫苗免疫接种的方式来控制免疫系统，使其能来识别和清除肿瘤细胞。
The paper illustrated the classification of tumor antigen, the mechanism of tumor cells escaping the immune system, antitumor and application of immunotherapy.
介绍肿瘤抗原分类、肿瘤细胞逃逸机体免疫监制的机制、机体抗肿瘤的免疫学机制和肿瘤抗原在免疫治疗中的应用。
Immunotherapy of tumor is extensively attentioned as an important part of combined therapy of tumor in recent years.
肿瘤的免疫治疗作为恶性肿瘤综合治疗的重要组成部分，近年来受到了广泛的关注。
The active immunotherapy of dendritic cells is hot in tumor therapy research area.
树突状细胞主动免疫治疗是近年来国内外肿瘤治疗研究的热点。
Saving-spleen operation is recommended for benign splenic tumor, and radical operation and postoperative radiochemotherapy and immunotherapy are important for splenic malignant tumor.
良性肿瘤尽量保脾，恶性肿瘤行根治性脾切除术及术后放化疗和免疫治疗等。
The development of technique to generate DCs has recently led to new approaches to cancer immunotherapy that will be the anti tumor mechanisms of this review.
DC在抗肿瘤免疫治疗策略中的变迁则源于对其抗肿瘤免疫机制的认识，就其近年的研究进展作一综述。
This research is going to studying the anti-tumor activity of tumor antigen induced cord blood cells based on the definition of adoptive immunotherapy.
本研究正是从过继性免疫细胞治疗的概念出发，探讨肿瘤抗原诱导的脐血细胞的抗肿瘤效应。
Conclusion: IL-18 in combination with IL-2 may increase the anti-tumor activity of NK92, which provides the experimental basis for immunotherapy of ovarian tumor with NK92 cells.
结论：IL - 18联合IL - 2可提高NK92细胞的抗肿瘤活性，为临床应用NK92细胞免疫治疗卵巢肿瘤提供了实验依据。
CONCLUSION: CIK cells have strong proliferative ability and higher cytotoxicity to tumor cells in vitro, which could be used as a potential anti-tumor adoptive immunotherapy in clinic.
结论：CIK细胞在体外扩增能力强，对肿瘤细胞的杀伤活性高，有望成为新一代抗肿瘤过继免疫细胞制剂而应用于临床。
Objective To explore the possibility of tumor associated antigen encoded by MAGE-1gene used as a tarest for immunotherapy in HCC patients.
目的探讨MAGE-1基因编码的肿瘤相关抗原作为肝细胞性肝癌（HCC）主动免疫治疗攻击靶点的可能性。
Objective To study the method of immunotherapy against t cell lymphoma by tumor cells transfected by GM-CSF gene combined with interleukin 12 (IL-12).
目的探讨用转粒细胞巨噬细胞集落刺激因子(GM CSF)基因瘤苗，联合白介素12 (IL 12)治疗小鼠t细胞淋巴瘤的方法。
Immunotherapy has drawn more and more attention from medicine following up surgery and chemoradiotherapy of tumor.
继手术、化疗、放疗之后免疫治疗越来越受到医学界的重视。
The cell used in adoptive immunotherapy must have strong cytotoxic and proliferative ability, so CIK cell is thought of the new generation anti-tumor adoptive immunity treatment.
用于过继免疫治疗的活性细胞必须具有较强的细胞活性和增殖力，CIK细胞被认为是新一代抗肿瘤过继细胞免疫治疗的首选方案。
Chapter 7 is immunotherapy for tumor;
第七章：肿瘤免疫疗法；
Chapter 7 is immunotherapy for tumor;
第七章：肿瘤免疫疗法；
应用推荐